Terms ending in 2043
Every in-force patent on Vanderbilt University's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,699,092 | Human Antibodies to Crimean Congo Hemorrhagic Fever Virus In force · High confidence | Vanderbilt University | In force | High confidence | |
| US 12,516,067 | Antagonists of the Muscarinic Acetylcholine Receptor M4 In force · High confidence | Vanderbilt University | In force | High confidence | |
| US 12,564,580 | Mitochondria-Targeted Isoketal/Isolevuglandin Scavengers and Uses Thereof In force · High confidence | Vanderbilt University | In force | High confidence | |
| US 12,590,935 | Bio-Identification Using Low Resolution Tandem Mass Spectrometry In force · High confidence | Triad National Security, LLC | In force | High confidence | |
| US 12,496,336 | Peptide Vaccine Based on a New Universal Influenza a Hemagglutinin Head Domain Epitope and Human Monoclonal Antibodies Binding Thereto In force · High confidence | The Scripps Research Institute | In force | High confidence | |
| US 12,594,320 | Method for Treating Checkpoint Inhibitors Induced Adverse Events Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (Inserm) and Vanderbilt University In force · High confidence | Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (Inserm) and Vanderbilt University | In force | High confidence | |
| US 12,521,389 | New Therapeutic Approach to Lung Disease In force · High confidence | Vanderbilt University and The Children's Hospital of Philadelphia | In force | High confidence | |
| US 12,275,145 | Method and Apparatus for Human Augmentation and Robot Actuation In force · High confidence | Vanderbilt University | In force | High confidence | |
| US 12,624,091 | HIV/Hcv Cross-Reactive Antibodies and Uses Thereof In force · High confidence | Vanderbilt University | In force | High confidence | |
| US 12,583,895 | Polypeptides for Restoring Endothelial Function and Methods of Use Thereof In force · High confidence | Vanderbilt University | In force | High confidence | |
| 24 more term ends in 2043 · Pro | |||||
10 of 34 patents shown. Soonest term end first, then patent number.
Pro members see all 34.
31 of these are in force and held by Vanderbilt University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.